Intellectual Property India Publishes Patent Application for A Novel Chemical Compound Against Receptor Tyrosine-Protien Kinase Erbb-2 (erbb2) For Ovarian Cancer

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202641123957 A) filed by Rk. Premeela on October 16, 2026, for A Novel Chemical Compound Against Receptor Tyrosine-Protien Kinase Erbb-2 (erbb2) For Ovarian Cancer.

Inventors include Rk. Premeela; and Dr. S. Deepa Rani.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: This invention presents a new chemical framework intended for specific anti-cancer effects through the use of sophisticated in silico methods. The molecule was created using a blend of computer-aided drug design (CADD) and drug repurposing methods, with its development, forecasting, and assessment completely automated. To assess its th...